|Expected size of offer (M):||£10m|
|Expected first date of trading:||08/05/2014|
|Location of address at which admission document will be available:||Copies of this document will be available free of charge to the public at the registered office of the Company's solicitors, Simmons & Simmons LLP, at CityPoint, One Ropemaker Street, London EC2Y 9SS during normal business hours on any weekday (Saturdays, Sundays and public holidays excepted) until the date falling one month after the date of Admission. Additionally, an electronic version of this document will be available on the Group's website www.rexbionics.com The Admission Document contains full details about the applicant and the admission of its securities.|
|Date at which admission document will be available:||-|
|Nominated Advisor (AIM Companies):||Oriel Securities Limited|
|Nominated Broker (AIM Companies):||Oriel Securities Limited|
|David Macfarlane||Non-Executive Chairman|
|Jeremy Curnock Cook||Chief Executive Officer|
|Peter Worrall||Chief Financial Officer|
|William (Bill) Hunter||Non-Executive Director|
|Fiscal year end:||31 March|
|Incorporated in:||England and Wales|
|Website URL:||www.rexbionics.com (as at admission)|
You will be redirected in five seconds.
You are accessing the London Stock Exchange Annual Report Service powered by PrecisionIR.
You will be redirected in five seconds